USPTO serial 79325347
IMPACTIVE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOBO, DEBORAH E
- Law office
- TMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with IMPACTIVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Topical skin creams, balms and gels containing derivatives of cannabis for medicinal purposes; CBD oil for medicinal purposes; CBD oil for treatment of pain; CBD oil for treatment of inflammation; CBD oil for general health and wellbeing; cannabis oil for medicinal purposes; cannabis oil for treatment of pain; cannabis oil for treatment of inflammation; cannabis oil for general health and wellbeing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 13, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 11, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 11, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 11, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 11, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 1, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 12, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 12, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 21, 2022 | RFNP | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 27, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 3, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 2, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 24, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 23, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 11, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |